Drug shortage: Clindamycin Phosphate Injection (CLINDAMYCIN IN 5 PERCENT DEXTROSE, CLEOCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE)
FDA lists 23 presentations as Current. Availability: Unavailable (4), Limited Availability (3), Available (10). Reason: Other; Discontinuation of the manufacture of the drug. Companies: Sandoz Inc., Pfizer Inc., Baxter Healthcare, Sagent Pharmaceuticals.
- Published by source
- 2023-03-21
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Sandoz Inc.
- Products
- Clindamycin Phosphate Injection CLINDAMYCIN IN 5 PERCENT DEXTROSE CLEOCIN PHOSPHATE CLINDAMYCIN PHOSPHATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Discontinuation of the manufacture of the drug
- Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-03-21
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #899 | new | 2026-10-22 | 61657936fdd9…f44c93 | 5fe09c8bb2c4…994d09 |
| #1135 | update | 2026-10-23 | dd42070c2f86…ceeb23 | 446d2b233308…06fd4e |
Chain head: #1250 0c9a4a81d7d8…29590d